Literature DB >> 24128805

Flattening-filter-free intensity modulated breath-hold image-guided SABR (Stereotactic ABlative Radiotherapy) can be applied in a 15-min treatment slot.

Judit Boda-Heggemann1, Sabine Mai, Jens Fleckenstein, Kerstin Siebenlist, Anna Simeonova, Michael Ehmann, Volker Steil, Frederik Wenz, Frank Lohr, Florian Stieler.   

Abstract

Hypofractionated image-guided stereotactic ablative radiotherapy (igSABR) is effective in small lung/liver lesions. Computer-assisted breath-hold reduces intrafraction motion but, as every gating/triggering strategy, reduces the duty cycle, resulting in long fraction times if combined with intensity-modulated radiotherapy (IMRT). 10 MV flattening-filter-free IMRT reduces daily fraction duration to <10 min for single doses of 5-20 Gy.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Breath hold; FFF; Image guidance; Lung; SABR

Mesh：

Year:  2013        PMID： 24128805     DOI： 10.1016/j.radonc.2013.09.014

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  16 in total

1.  MRI morphologic alterations after liver SBRT : Direct dose correlation with intermodal matching.

Authors:  Judit Boda-Heggemann; Ulrike Attenberger; Johannes Budjan; Anika Jahnke; Lennart Jahnke; Lena Vogel; Anna O Simeonova-Chergou; Carsten Herskind; Frederik Wenz; Frank Lohr
Journal:  Strahlenther Onkol       Date:  2016-07-08       Impact factor: 3.621

2.  Impact of flattening-filter-free radiation on the clonogenic survival of astrocytic cell lines.

Authors:  Caroline Steenken; Jens Fleckenstein; Stefan Kegel; Lennart Jahnke; Anna Simeonova; Linda Hartmann; Jens Kübler; Marlon R Veldwijk; Frederik Wenz; Carsten Herskind; Frank Anton Giordano
Journal:  Strahlenther Onkol       Date:  2015-03-13       Impact factor: 3.621

3.  Automatically gated image-guided breath-hold IMRT is a fast, precise, and dosimetrically robust treatment for lung cancer patients.

Authors:  Anna Simeonova-Chergou; Anika Jahnke; Kerstin Siebenlist; Florian Stieler; Sabine Mai; Judit Boda-Heggemann; Frederik Wenz; Frank Lohr; Lennart Jahnke
Journal:  Strahlenther Onkol       Date:  2016-01-15       Impact factor: 3.621

4.  Non-coplanar VMAT combined with non-uniform dose prescription markedly reduces lung dose in breath-hold lung SBRT.

Authors:  Jens Fleckenstein; Judit Boda-Heggemann; Kerstin Siebenlist; Tanya Gudzheva; Natallia Prakofyeva; Frank Lohr; Frederik Wenz; Anna Simeonova-Chergou
Journal:  Strahlenther Onkol       Date:  2018-05-25       Impact factor: 3.621

5.  Towards clinical implementation of ultrafast combined kV-MV CBCT for IGRT of lung cancer : Evaluation of registration accuracy based on phantom study.

Authors:  Anna Arns; Manuel Blessing; Jens Fleckenstein; Dzmitry Stsepankou; Judit Boda-Heggemann; Anna Simeonova-Chergou; Jürgen Hesser; Frank Lohr; Frederik Wenz; Hansjörg Wertz
Journal:  Strahlenther Onkol       Date:  2016-02-10       Impact factor: 3.621

6.  Time motion study to evaluate the impact of flattening filter free beam on overall treatment time for frameless intracranial radiosurgery using Varian TrueBeam® linear accelerator.

Authors:  Gopinath Mamballikalam; S Senthilkumar; C O Clinto; P M Ahamed Basith; R C Jaon Bos; Tems Thomas
Journal:  Rep Pract Oncol Radiother       Date:  2021-02-25

7.  Using FFF Beams to Improve the Therapeutic Ratio of Lung SBRT.

Authors:  Oleg N Vassiliev; Christine B Peterson; Joe Y Chang; Radhe Mohan
Journal:  J Radiother Pract       Date:  2020-07-30

8.  Safety of high-dose-rate stereotactic body radiotherapy.

Authors:  Sonja Stieb; Stephanie Lang; Claudia Linsenmeier; Shaun Graydon; Oliver Riesterer
Journal:  Radiat Oncol       Date:  2015-01-23       Impact factor: 3.481

9.  Commissioning an Elekta Versa HD linear accelerator.

Authors:  Ganesh Narayanasamy; Daniel Saenz; Wilbert Cruz; Chul S Ha; Niko Papanikolaou; Sotirios Stathakis
Journal:  J Appl Clin Med Phys       Date:  2016-01-08       Impact factor: 2.102

10.  Re-irradiating spinal column metastases using IMRT and VMAT with and without flattening filter - a treatment planning study.

Authors:  Barbara Dobler; Amine Khemissi; Tina Obermeier; Matthias G Hautmann; Zaira Katsilieri; Oliver Kölbl
Journal:  Radiat Oncol       Date:  2016-03-01       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.